Open access
Sep 2026
Mucosal adjuvant activity of a PAR-2-activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime-boost influenza vaccination model.
It is demonstrated that PAR-2 activation functions as a potent mucosal adjuvant by enhancing early immune cell recruitment, DC activation, and adaptive T cell responses in lymph nodes, ultimately promoting tissue-resident immunity.
C. Kornuta, Gang Zhou, K. Kane et al.
· Vaccine · 0 citations